Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators

다국어 초록 (Multilingual Abstract)

Necroptosis is a form of programmed necrosis that is mediated by various cytokines and pattern recognition receptors (PRRs). Cells dying by necroptosis show necrotic phenotypes, including swelling and membrane rupture, and release damage-associated molecular patterns (DAMPs), inflammatory cytokines, and chemokines, thereby mediating extreme inflammatory responses. Studies on gene knockout or necroptosis-specific inhibitor treatment in animal models have provided extensive evidence regarding the important roles of necroptosis in inflammatory diseases. The necroptosis signaling pathway is primarily modulated by activation of receptor-interacting protein kinase 3 (RIPK3), which phosphorylates mixed-lineage kinase domain-like protein (MLKL), mediating MLKL oligomerization. In the necroptosis process, these proteins are fine-tuned by posttranslational regulation via phosphorylation, ubiquitination, glycosylation, and protein–protein interactions. Herein, we review recent findings on the molecular regulatory mechanisms of necroptosis.

참고문헌 (Reference)

1 Menon, M. B., "p38(MAPK)/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection" 19 : 1248-1259, 2017

2 Feoktistova, M., "cIAPs block ripoptosome formation, a RIP1/caspase-8containing intracellular cell death complex differentially regulated by cFLIP isoforms" 43 : 449-463, 2011

3 Bertrand, M. J., "cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination" 30 : 689-700, 2008

4 Jiao, H., "Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation" 580 : 391-395, 2020

5 Annibaldi, A., "Ubiquitin-mediated regulation of RIPK1 kinase activity independent of IKK and MK2" 69 : 566-580, 2018

6 Strilic, B., "Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis" 536 : 215-218, 2016

7 Chen, X., "Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death" 24 : 105-121, 2014

8 He, S., "Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway" 108 : 20054-20059, 2011

9 Kaiser, W. J., "Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL" 288 : 31268-31279, 2013

10 Onizawa, M., "The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis" 16 : 618-627, 2015

11 Kovalenko, A., "The tumour suppressor CYLD negatively regulates NFkappaB signalling by deubiquitination" 424 : 801-805, 2003

12 Seo, J., "The roles of ubiquitination in extrinsic cell death pathways and its implications for therapeutics" 162 : 21-40, 2019

13 Murphy, J. M., "The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism" 39 : 443-453, 2013

14 Wang, Z., "The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways" 148 : 228-243, 2012

15 Davies, K. A., "The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis" 25 : 1567-1580, 2018

16 Li, J., "The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis" 150 : 339-350, 2012

17 Lee, S. B., "The AMPK-Parkin axis negatively regulates necroptosis and tumorigenesis by inhibiting the necrosome" 21 : 940-951, 2019

18 Petersen, S. L., "TRAF2 is a biologically important necroptosis suppressor" 22 : 1846-1857, 2015

19 Xu, D., "TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging" 174 : 1477-1491, 2018

20 Lafont, E., "TBK1 and IKKepsilon prevent TNF-induced cell death by RIPK1 phosphorylation" 20 : 1389-1399, 2018

21 Najafov, A., "TAM kinases promote necroptosis by regulating oligomerization of MLKL" 75 : 457-468, 2019

22 Xie, T., "Structural insights into RIP3-mediated necroptotic signaling" 5 : 70-78, 2013

23 Dondelinger, Y., "Serine 25 phosphorylation inhibits RIPK1 kinase dependent cell death in models of infection and inflammation" 10 : 1729-, 2019

24 Quarato, G., "Sequential engagement of distinct MLKL phosphatidylinositol-binding sites executes necroptosis" 61 : 589-601, 2016

25 Maelfait, J., "Sensing of viral and endogenous RNA by ZBP1/DAI induces necroptosis" 36 : 2529-2543, 2017

26 Tokunaga, F., "SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex" 471 : 633-636, 2011

27 Ikeda, F., "SHARPIN forms a linear ubiquitin ligase complex regulating NFkappaB activity and apoptosis" 471 : 637-641, 2011

28 Amin, P., "Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFalpha-mediated apoptosis" 115 : E5944-E5953, 2018

29 Geng, J., "Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis" 8 : 359-, 2017

30 Haas, T. L., "Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction" 36 : 831-844, 2009

31 Mifflin, L., "Receptor-interacting protein kinase 1(RIPK1)as a therapeutic target" 19 : 553-571, 2020

32 He, S., "Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha" 137 : 1100-1111, 2009

33 Newton, K., "RIPK1 inhibits ZBP1-driven necroptosis during development" 540 : 129-133, 2016

34 Lin, J., "RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation" 540 : 124-128, 2016

35 Zhang, D. W., "RIP3, an energy metabolism regulator that switches TNF induced cell death from apoptosis to necrosis" 325 : 332-336, 2009

36 Mandal, P., "RIP3 induces apoptosis independent of pronecrotic kinase activity" 56 : 481-495, 2014

37 Zhang, Y., "RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome" 8 : 14329-, 2017

38 He, S., "RIP kinases as modulators of inflammation and immunity" 19 : 912-922, 2018

39 Kim, E. H., "Programmed necrosis and disease:we interrupt your regular programming to bring you necroinflammation" 26 : 25-40, 2019

40 Chen, W., "Ppm1b negatively regulates necroptosis through dephosphorylating Rip3" 17 : 434-444, 2015

41 Cho, Y. S., "Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation" 137 : 1112-1123, 2009

42 Choi, S. W., "PELI1 selectively targets kinase-active RIP3 for ubiquitylationdependent proteasomal degradation" 70 : 920-935, 2018

43 Wang, H., "PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP" 114 : 11944-11949, 2017

44 Keusekotten, K., "OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin" 153 : 1312-1326, 2013

45 Li, X., "O-GlcNAc transferase suppresses inflammation and necroptosis by targeting receptor-interacting serine/threonine-protein kinase 3" 50 : 576-590, 2019

46 Galluzzi, L., "Necroptosis: mechanisms and relevance to disease" 12 : 103-130, 2017

47 Choi, M. E., "Necroptosis: a crucial pathogenic mediator of human disease" 4 : e128834-, 2019

48 Johnston, A. N., "Necroptosis-blocking compound NBC1 targets heat shock protein 70 to inhibit MLKL polymerization and necroptosis" 117 : 6521-6530, 2020

49 Tanzer, M. C., "Necroptosis signalling is tuned by phosphorylation of MLKL residues outside the pseudokinase domain activation loop" 471 : 255-265, 2015

50 Khoury, M. K., "Necroptosis in the pathophysiology of disease" 190 : 272-285, 2020

51 Pasparakis, M., "Necroptosis and its role in inflammation" 517 : 311-320, 2015

52 Xia, X., "Necroptosis and its role in infectious diseases" 25 : 169-178, 2020

53 Dondelinger, Y., "NF-kappaB-independent role of IKKalpha/IKKbeta in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling" 60 : 63-76, 2015

54 Enesa, K., "NF-kappaB suppression by the deubiquitinating enzyme Cezanne : a novel negative feedback loop in pro-inflammatory signaling" 283 : 7036-7045, 2008

55 Galluzzi, L., "Molecular mechanisms of cell death : recommendations of the Nomenclature Committee on Cell Death 2018" 25 : 486-541, 2018

56 Sun, L., "Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase" 148 : 213-227, 2012

57 Wang, H., "Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3" 54 : 133-146, 2014

58 Feltham, R., "Mind bomb regulates cell death during TNF signaling by suppressing RIPK1’s cytotoxic potential" 23 : 470-484, 2018

59 Samson, A. L., "MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis" 11 : 3151-, 2020

60 Xia, B., "MLKL forms cation channels" 26 : 517-528, 2016

61 Dondelinger, Y., "MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death" 19 : 1237-1247, 2017

62 Jaco, I., "MK2 phosphorylates RIPK1 to prevent TNF-induced cell death" 66 : 698-710, 2017

63 Brummelkamp, T. R., "Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NFkappaB" 424 : 797-801, 2003

64 Gerlach, B., "Linear ubiquitination prevents inflammation and regulates immune signalling" 471 : 591-596, 2011

65 Draber, P., "LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes" 13 : 2258-2272, 2015

66 Taraborrelli, L., "LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L" 9 : 3910-, 2018

67 Peltzer, N., "LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis" 557 : 112-117, 2018

68 Tokunaga, F., "Involvement of linear polyubiquitylation of NEMO in NFkappaB activation" 11 : 123-132, 2009

69 Xie, Y., "Inhibition of aurora kinase A induces Necroptosis in Pancreatic Carcinoma" 153 : 1429-1443, 2017

70 Yu, P. W., "Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB" 9 : 539-542, 1999

71 Degterev, A., "Identification of RIP1 kinase as a specific cellular target of necrostatins" 4 : 313-321, 2008

72 Seong, D., "Identification of MYC as an antinecroptotic protein that stifles RIPK1-RIPK3 complex formation" 117 : 19982-19993, 2020

73 Varfolomeev, E., "IAP antagonists induce autoubiquitination of c-IAPs, NFkappaB activation, and TNFalpha-dependent apoptosis" 131 : 669-681, 2007

74 Zhao, X. M., "Hsp90 modulates the stability of MLKL and is required for TNF-induced necroptosis" 7 : e2089-, 2016

75 Jacobsen, A. V., "HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death" 7 : e2051-, 2016

76 Peltzer, N., "HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death" 9 : 153-165, 2014

77 Harris, P. A., "Discovery of a first-in-class receptor interacting protein 1(RIP1)kinase specific clinical candidate(GSK2982772)for the treatment of inflammatory diseases" 60 : 1247-1261, 2017

78 Bittner, S., "Death receptor 3 mediates necroptotic cell death" 74 : 543-554, 2017

79 Wertz, I. E., "De-ubiquitination and ubiquitin ligase domains of A20downregulate NF-kappaB signalling" 430 : 694-699, 2004

80 Upton, J. W., "DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA" 11 : 290-297, 2012

81 Thapa, R. J., "DAI senses influenza A virus genomic RNA and activates RIPK3-dependent cell death" 20 : 674-681, 2016

82 Molnar, T., "Current translational potential and underlying molecular mechanisms of necroptosis" 10 : 860-, 2019

83 Petrie, E. J., "Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis" 9 : 2422-, 2018

84 Wallach, D., "Concepts of tissue injury and cell death in inflammation: a historical perspective" 14 : 51-59, 2014

85 Degterev, A., "Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury" 1 : 112-119, 2005

86 Annibaldi, A., "Checkpoints in TNF-induced cell death : implications in inflammation and cancer" 24 : 49-65, 2018

87 Berger, S. B., "Characterization of GSK’963 : a structurally distinct, potent and selective inhibitor of RIP1 kinase" 1 : 15009-, 2015

88 Geserick, P., "Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment" 187 : 1037-1054, 2009

89 Lee, S. Y., "Casein kinase-1gamma1 and 3 stimulate tumor necrosis factorinduced necroptosis through RIPK3" 10 : 923-, 2019

90 Hanna-Addams, S., "CK1alpha, CK1delta, and CK1epsilon are necrosome components which phosphorylate serine 227 of human RIPK3 to activate necroptosis" 117 : 1962-1970, 2020

91 Seo, J., "CHIP controls necroptosis through ubiquitylation-and lysosomedependent degradation of RIPK3" 18 : 291-302, 2016

92 Seo, J., "Beclin 1 functions as a negative modulator of MLKL oligomerisation by integrating into the necrosome complex" 27 : 3065-3081, 2020

93 Shi, C. S., "Bcl-2 regulates pyroptosis and necroptosis by targeting BH3-like domains in GSDMD and MLKL" 5 : 151-, 2019

94 Hildebrand, J. M., "Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death" 111 : 15072-15077, 2014

95 Su, L., "A plug release mechanism for membrane permeation by MLKL" 22 : 1489-1500, 2014

96 Li, D., "A cytosolic heat shock protein 90 and cochaperone CDC37complex is required for RIP3 activation during necroptosis" 112 : 5017-5022, 2015